[1]
Yeremchenko О.A. 2018. Alternative strategies for investing in corporate R&D (on the example of the global pharmaceutical industry). Economics of Science. 4, 4 (Dec. 2018), 309–317. DOI:https://doi.org/10.22394/2410-132X-2018-4-4-309-317.